ME/CFS has a broad spectrum of severity, with some able to work while others require total care and support. People living with Severe ME are often confined to their beds […]
**NEW TIME AND DATE!** In 2021 the National Institutes of Health (NIH) launched the RECOVER Initiative, a patient-centered, integrated, adaptive research network created to study Long Covid. Included in the […]
**NEW DATE: Tuesday, January 21 @ 10 am PT** ME/CFS has a broad spectrum of severity, with some able to work while others require total care and support. People living […]
Join us for a webinar on April 29 from 3-4 pm PT / 6-7 pm ET with Solve Ramsay Research Grant winners Liisa K. Selin, MD, PhD, and Anna Gil, […]
One of the cornerstones of our annual Advocacy Week program is the EmPOWER M.E. roundtable. Panels of patient advocates, professionals, and scientists share their expertise on topics relevant to the […]
In this webinar, we’ll be joined by panelists Michael Peluso, MD (Assistant Professor of Medicine, University of California, San Francisco) Ezra Spier (Creator, Long Covid Studies), Penelope Markham, PhD (Senior […]
Dr. Akiko Iwasaki (Sterling Professor of Immunobiology and Molecular, Cellular and Developmental Biology at Yale University) is the first recipient of Solve’s ME/CFS Catalyst Award in support of her study, […]
Simmaron Research is the second recipient of Solve’s ME/CFS Catalyst Award in support of its study,” “Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection-Associated Chronic Conditions.” Read a preprint from Phase 1 of the trial here. The study advances an already FDA-approved drug for reducing key symptoms of ME/CFS and Long Covid, repurposing rapamycin […]
Chronic illnesses such as myalgic encephalomyelitis (ME) and Long COVID, which lack clinical biomarkers, present challenges around diagnosis, symptom reporting, and monitoring. That’s why the unhide® Solve Together Unified Platform–which is participant-led with continuous digital data collection–offers some advantages over traditional site-based clinical research models. The easy-to-use, secure platform allows patients to contribute data through […]
For the first time, scientists have developed a simple, accurate blood test that can potentially identify Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) — a long-term, debilitating condition that affects millions of patients worldwide. The study (published in the Journal of Translational Medicine), led by the University of East Anglia in partnership with Oxford BioDynamics, […]
Caring for someone with ME/CFS is an act of deep love–and preparation is one of the most meaningful ways to protect their future. Hosted by Solve M.E. Director of Advocacy Monique Wike, Andrew Kantor, Esq. (Senior Partner at Kantor & Kantor, LLP), will walk caregivers through essential legal and insurance strategies to support a loved […]
Glucagon-Like Peptide-1 (GLP-1) agonist medications, like semaglutide, are injectable or oral drugs that mimic the natural GLP-1 hormone, which helps regulate insulin levels. Thus, these medicines help control blood sugar in people with Type 2 diabetes and promote substantial weight loss for individuals with a high body mass index (BMI) by slowing digestion, reducing appetite, […]
